Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-053945
Filing Date
2025-04-15
Accepted
2025-04-15 07:15:25
Documents
83
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sprb-20241231.htm   iXBRL 10-K 2801052
2 EX-2.1 sprb-ex2_1.htm EX-2.1 369516
3 EX-4.7 sprb-ex4_7.htm EX-4.7 236529
4 EX-10.26 sprb-ex10_26.htm EX-10.26 405541
5 EX-10.27 sprb-ex10_27.htm EX-10.27 862788
6 EX-10.28 sprb-ex10_28.htm EX-10.28 1406136
7 EX-19.1 sprb-ex19_1.htm EX-19.1 79528
8 EX-23.1 sprb-ex23_1.htm EX-23.1 6056
9 EX-31.1 sprb-ex31_1.htm EX-31.1 17576
10 EX-31.2 sprb-ex31_2.htm EX-31.2 17861
11 EX-32.1 sprb-ex32_1.htm EX-32.1 10534
12 EX-32.2 sprb-ex32_2.htm EX-32.2 10531
  Complete submission text file 0000950170-25-053945.txt   13693369

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20241231.xsd EX-101.SCH 1428110
86 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20241231_htm.xml XML 1437731
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39594 | Film No.: 25837554
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)